Rhythm Pharmaceuticals (RYTM) Financials: Revenue & Earnings

RYTM price $92.00 -0.18 -0.20%

Ticker
RYTM
Price
$92.00
Change
-0.18 -0.20%
Market cap ?
$6.33B
P/E ?
-29.62
Forward P/E ?
35.26
Dividend yield ?
0.00%
Beta ?
2.01
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
61
Value
38
Quality
46
Growth
100

Stocklytics score rationale: value 38, quality 46, growth 100.

Financials

2016201720182019202020212022202320242025
0000031540002363800077428000130126000189757000

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company with commercial products, dedicated to the discovery, development, and market launch of therapies addressing rare genetic conditions that cause obesity. Its leading pharmaceutical, IMCIVREE, functions as a powerful agonist of the melanocortin-4 receptor (MC4R). This medication is indicated for treating obesity stemming from deficiencies in…

Fair value

RYTM fair value $102.72. Price $92.00. Price is 10% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare RYTM

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-03—-0.71—85.47M
2026-08-04-0.73-0.8171.25M67.66M
2026-05-05-0.83-0.8660.11M55.78M
2026-02-26-0.73-0.7957.25M56.21M
2025-11-04-0.82-0.7251.30M55.98M
2025-08-05-0.75-0.6648.50M51.33M
2025-05-07-0.81-0.6932.70M43.28M
2025-02-26-0.72-0.6941.83M38.48M
2024-11-05-0.73-0.8033.25M35.93M
2024-08-06-0.55-0.7029.08M28.79M
2024-05-07-2.35-2.3425.97M28.79M
2024-02-22-0.70-0.7024.23M25.38M
2023-11-07-0.76-0.7622.50M26.35M
2023-08-01-0.82-0.8019.22M22.96M
2023-05-02-0.92-0.7111.47M12.12M
2023-03-01-0.75-0.828.79M7.22M
2022-11-08-0.79-1.014.28M4.76M
2022-08-02-0.89-0.799.07M2.57M
2022-05-03-1.05-0.981.50M2.30M
2022-03-01-0.85-1.001.82M1.70M
2021-11-02-0.70-0.841.03M940.00K
2021-08-03-0.70-0.75274.00K274.00K
2021-05-030.90-0.2335.00K35.00K
2021-03-01-0.79-0.81——
2020-11-02-0.77-0.83——
2020-08-03-0.71-0.83——
2020-05-04-0.78-0.80——
2020-03-02-0.78-0.91——
2019-11-01-1.04-1.05——
2019-07-29-1.24-0.81——
2019-05-03-0.84-0.69——
2019-03-08-0.74-0.56——
2018-11-09-0.52-0.41——
2018-08-08-0.52-0.40——
2018-05-14-0.60-0.45——
2018-03-12-0.41-0.55——
2017-11-14-1.51-0.40——
2017-10-05-0.26———
2017-03-31-0.38———
2016-12-31-0.50———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-14Meeker David PBuy50.00K$6.05302.50K
2026-09-14Meeker David PSell6.44K$101.75655.15K
2026-09-14Meeker David PSell30.75K$102.353.15M
2026-09-14Meeker David PSell8.70K$103.43899.63K
2026-09-14Meeker David PSell1.82K$104.55189.96K
2026-09-14Meeker David PSell2.30K$105.19241.94K
2026-09-14Meeker David PSell50.00K$6.05302.50K
2026-08-31Smith Hunter CBuy57.19K$25.791.47M
2026-08-31Smith Hunter CSell23.07K$104.592.41M
2026-08-31Smith Hunter CSell11.51K$105.371.21M
2026-08-31Smith Hunter CSell28.19K$106.202.99M
2026-08-31Smith Hunter CSell57.19K$25.791.47M
2026-08-17Joshi ManherBuy50.00K$115.445.77M
2026-08-17Joshi ManherBuy25.00K——
2026-08-17Joshi ManherOther0——
2026-08-13Shulman JosephBuy2.02K$6.8013.76K
2026-08-13Shulman JosephSell5.08K$119.75608.21K
2026-08-13Shulman JosephSell2.02K$6.8013.76K
2026-08-13Garfield AlastairSell2.01K$116.11233.03K
2026-08-13Garfield AlastairSell1.56K$117.08182.17K
2026-08-13Garfield AlastairSell3.40K$118.28402.17K
2026-08-13Garfield AlastairSell800$119.1795.34K
2026-08-13Lee Jennifer KaydenBuy21.60K$6.80146.89K
2026-08-13Lee Jennifer KaydenBuy35.00K$24.29850.15K
2026-08-13Lee Jennifer KaydenSell35.00K$24.29850.15K
2026-08-13Lee Jennifer KaydenSell21.60K$6.80146.89K
2026-08-13Lee Jennifer KaydenSell75.83K$117.388.90M
2026-08-12Mazabraud YannBuy46.62K$6.80317.05K
2026-08-12Mazabraud YannSell2.30K$111.80257.14K
2026-08-12Mazabraud YannSell1.00K$112.86112.86K
2026-08-12Mazabraud YannSell3.60K$114.70413.48K
2026-08-12Mazabraud YannSell14.57K$115.431.68M
2026-08-12Mazabraud YannSell18.21K$116.492.12M
2026-08-12Mazabraud YannSell17.32K$117.472.03M
2026-08-12Mazabraud YannSell46.62K$6.80317.05K
2026-07-01Garfield AlastairBuy4.45K——
2026-07-01Garfield AlastairSell2.15K$110.41237.38K
2026-07-01Garfield AlastairSell4.45K——
2026-06-24JEAN CHRISTOPHEBuy3.69K$107.55396.97K
2026-06-24JEAN CHRISTOPHEBuy2.32K——
2026-06-24MCGIRR DAVID W JBuy3.69K$107.55396.97K
2026-06-24MCGIRR DAVID W JBuy2.32K——
2026-06-24TETRAULT LYNN A.Buy3.69K$107.55396.97K
2026-06-24TETRAULT LYNN A.Buy2.32K——
2026-06-24Arbuckle Stuart ABuy3.69K$107.55396.97K
2026-06-24Arbuckle Stuart ABuy2.32K——
2026-06-24GOOD JENNIFER LBuy3.69K$107.55396.97K
2026-06-24GOOD JENNIFER LBuy2.32K——
2026-06-23JEAN CHRISTOPHEBuy4.71K——
2026-06-23JEAN CHRISTOPHESell4.71K——
2026-06-23MCGIRR DAVID W JBuy4.71K——
2026-06-23MCGIRR DAVID W JSell4.71K——
2026-06-23TETRAULT LYNN A.Buy4.71K——
2026-06-23TETRAULT LYNN A.Sell4.71K——
2026-06-23Arbuckle Stuart ABuy4.71K——
2026-06-23Arbuckle Stuart ASell4.71K——
2026-06-23GOOD JENNIFER LBuy4.71K——
2026-06-23GOOD JENNIFER LSell4.71K——
2026-06-22TETRAULT LYNN A.Buy37.00K$28.271.05M
2026-06-22TETRAULT LYNN A.Sell37.00K$100.323.71M
2026-06-22TETRAULT LYNN A.Sell37.00K$28.271.05M
2026-05-18Smith Hunter CBuy3.00K$17.8753.61K
2026-05-18Smith Hunter CSell3.00K$17.8753.61K
2026-05-15German Christopher PaulBuy1.41K$17.9725.27K
2026-05-15German Christopher PaulSell1.69K$56.6995.64K
2026-05-15German Christopher PaulBuy1.35K$49.2366.41K
2026-05-15German Christopher PaulSell1.35K$49.2366.41K
2026-05-15German Christopher PaulSell1.41K$17.9725.27K
2026-05-15German Christopher PaulBuy1.69K$56.6995.64K
2026-05-15German Christopher PaulSell4.64K$92.21428.13K
2026-04-01Mazabraud YannBuy12.88K——
2026-04-01Mazabraud YannSell10.38K——
2026-04-01Mazabraud YannSell2.50K——
2026-04-01Popovits Kimberly JBuy10.26K$88.12903.85K
2026-04-01Popovits Kimberly JBuy6.81K——
2026-04-01Popovits Kimberly JOther0——
2026-03-12Mathers Edward TBuy4.20K——
2026-03-04German Christopher PaulBuy1.50K$17.9726.95K
2026-03-04German Christopher PaulSell1.50K$17.9726.95K
2026-03-04German Christopher PaulSell5.61K$89.56502.79K
2026-03-02Mazabraud YannBuy35.00K$94.943.32M
2026-03-02Mathers Edward TBuy4.20K——
2026-03-02Smith Hunter CBuy6.10K$6.8041.47K
2026-03-02Smith Hunter CSell6.10K$6.8041.47K
2026-03-01German Christopher PaulBuy1.16K——
2026-03-01German Christopher PaulSell342$94.9432.47K
2026-03-01German Christopher PaulSell1.16K——
2026-02-19Smith Hunter CSell1.31K$100.27131.15K
2026-02-19Smith Hunter CSell1.69K$100.92170.75K
2026-02-19Smith Hunter CSell800$102.1081.68K
2026-02-19Smith Hunter CSell585$103.2860.42K
2026-02-17Smith Hunter CSell1.20K$99.42119.30K
2026-02-17Smith Hunter CSell200$100.5220.10K
2026-02-17Smith Hunter CSell900$101.7091.53K
2026-02-17Smith Hunter CSell1.07K$103.00110.11K
2026-02-17Smith Hunter CSell200$103.8420.77K
2026-02-14Mazabraud YannBuy10.00K——
2026-02-14Mazabraud YannSell10.00K——
2026-02-12Smith Hunter CSell292$96.2628.11K
2026-02-12Smith Hunter CSell400$97.6739.07K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 313, holders +22 vs prior quarter. Ownership 113.40%.

HolderSharesChangeChange %Value
RA CAPITAL MANAGEMENT, L.P.6.67M00.00%740.22M
BLACKROCK, INC.6.16M-80.25K-1.29%683.60M
BAKER BROS. ADVISORS LP5.60M00.00%622.27M
PRIMECAP MANAGEMENT CO/CA/3.17M-248.66K-7.28%351.84M
VANGUARD PORTFOLIO MANAGEMENT LLC3.14M96.18K+3.16%348.29M
VANGUARD CAPITAL MANAGEMENT LLC3.01M38.15K+1.29%333.75M
JPMORGAN CHASE & CO2.65M1.10M+70.74%292.18M
PERCEPTIVE ADVISORS LLC2.59M212.50K+8.95%287.16M
STATE STREET CORP2.57M301.68K+13.28%285.73M
PRICE T ROWE ASSOCIATES INC /MD/2.57M911.29K+55.07%284.92M
WESTFIELD CAPITAL MANAGEMENT CO LP2.21M279.47K+14.49%245.22M
GOLDMAN SACHS GROUP INC2.13M161.07K+8.20%236.11M
FEDERATED HERMES, INC.1.79M499.41K+38.83%198.27M
POLAR CAPITAL HOLDINGS PLC1.66M48.05K+2.97%184.71M
GEODE CAPITAL MANAGEMENT, LLC1.53M117.43K+8.29%170.32M
CAPITAL RESEARCH GLOBAL INVESTORS1.53M416.84K+37.37%170.13M
CITADEL ADVISORS LLC1.26M-154.97K-10.92%140.30M
CHECKPOINT CAPITAL L.P.1.19M-41.20K-3.36%131.68M
SIREN, L.L.C.1.14M410.76K+56.62%126.16M
MORGAN STANLEY1.11M408.26K+57.99%123.49M
FMR LLC1.03M-663.83K-39.29%113.90M
PICTET ASSET MANAGEMENT HOLDING SA957.78K290.74K+43.59%106.25M
JUPITER TOPCO LLC925.49K925.49KNew102.75M
WOODLINE PARTNERS LP758.89K00.00%84.26M
ALLIANCEBERNSTEIN L.P.894.72K-15.69K-1.72%77.81M

Earnings and financials

Rhythm Pharmaceuticals, Inc. (RYTM) trades at $92.00, with a market cap of $6.33B and a trailing P/E of -29.62. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
0000031540002363800077428000130126000189757000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Rhythm Pharmaceuticals (RYTM) Financials: Revenue & Earnings

RYTM$92.00-0.18 -0.20%

$6.33B

Market Cap

-29.62

P/E

35.26

Forward P/E

61

Score

Price History